Identification a Novel Inhibitor for Aldo–Keto Reductase 1 C3 by Virtual Screening of PubChem Database-Reference-Cited by-同舟云学术

Identification a Novel Inhibitor for Aldo–Keto Reductase 1 C3 by Virtual Screening of PubChem Database

Published:2022-02-10 Issue:3 Volume:92 Page:569-573
ISSN:0369-8211
Container-title:Proceedings of the National Academy of Sciences, India Section B: Biological Sciences
language:en
Short-container-title:Proc. Natl. Acad. Sci., India, Sect. B Biol. Sci.

Author:

Pourabouk Mona,Mohammadhosseini Mana,Mahmoodjanloo Mehr Ali,Rashidbaghan Azam

Publisher

Springer Science and Business Media LLC

Subject

General Agricultural and Biological Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s40011-021-01335-x.pdf

Reference15 articles.

1. Rizner L, Penning TM (2014) Role of Aldo–Keto reductase family 1 (AKR1) enzymes in human steroid metabolism Tea. Steroids 79:49–63. https://doi.org/10.1016/j.steroids.2013.10.012

2. Chang TS, Lin HK, Rogers KA, Brame LS, Yeh MM, Yang Q, Fung KM (2013) Expression of Aldo-Keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors and adenocarcinomas of pancreas, gastrointestinal tract, and lung. Int J Clin Exp Pathol 6(11):2419–2429

3. Penning TM (2017) Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review. Expert Opin Ther Pat 27(12):1329–1340. https://doi.org/10.1080/13543776.2017.1379503

4. Zeng CM, Chang LL, Ying MD, Cao J, He QJ, Zhu H, Yang B (2017) Aldo–Keto reductase AKR1C1–AKR1C4: functions, regulation, and intervention for anti-cancer therapy. Front Pharmacol 8:119. https://doi.org/10.3389/fphar.2017.00119

5. Lovering AL, Ride JP, Bunce CM, Desmond JC, Cummings SM, White SA (2004) Crystal structures of prostaglandin D2 11-ketoreductase (AKR1C3) in complex with the nonsteroidal anti-inflammatory drugs flufenamic acid and indomethacin. Cancer Res 64:1802–1810. https://doi.org/10.1158/0008-5472.CAN-03-2847